255 related articles for article (PubMed ID: 20736187)
1. Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia.
Vucic S; Cheah BC; Yiannikas C; Vincent A; Kiernan MC
Brain; 2010 Sep; 133(9):2727-33. PubMed ID: 20736187
[TBL] [Abstract][Full Text] [Related]
2. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
3. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181
[TBL] [Abstract][Full Text] [Related]
4. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS.
Menon P; Kiernan MC; Vucic S
Clin Neurophysiol; 2015 Apr; 126(4):803-9. PubMed ID: 25227219
[TBL] [Abstract][Full Text] [Related]
5. Cortical hyperexcitability evolves with disease progression in ALS.
Menon P; Higashihara M; van den Bos M; Geevasinga N; Kiernan MC; Vucic S
Ann Clin Transl Neurol; 2020 May; 7(5):733-741. PubMed ID: 32304186
[TBL] [Abstract][Full Text] [Related]
6. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.
Farrar MA; Vucic S; Johnston HM; Kiernan MC
Arch Neurol; 2012 Apr; 69(4):467-73. PubMed ID: 22491191
[TBL] [Abstract][Full Text] [Related]
7. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.
Vucic S; Nicholson GA; Kiernan MC
Brain; 2008 Jun; 131(Pt 6):1540-50. PubMed ID: 18469020
[TBL] [Abstract][Full Text] [Related]
8. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS.
Vucic S; Nicholson GA; Kiernan MC
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):97-100. PubMed ID: 20019225
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
[TBL] [Abstract][Full Text] [Related]
10. Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation.
Suzuki YI; Ma Y; Shibuya K; Misawa S; Suichi T; Tsuneyama A; Nakamura K; Matamala JM; Dharmadasa T; Vucic S; Fan D; Kiernan MC; Kuwabara S
J Neurophysiol; 2021 Sep; 126(3):840-844. PubMed ID: 34406906
[TBL] [Abstract][Full Text] [Related]
11. Cortical function and corticomotoneuronal adaptation in monomelic amyotrophy.
Matamala JM; Geevasinga N; Huynh W; Dharmadasa T; Howells J; Simon NG; Menon P; Vucic S; Kiernan MC
Clin Neurophysiol; 2017 Aug; 128(8):1488-1495. PubMed ID: 28624492
[TBL] [Abstract][Full Text] [Related]
12. Cortical hyperexcitability and the split-hand plus phenomenon: pathophysiological insights in ALS.
Bae JS; Menon P; Mioshi E; Kiernan MC; Vucic S
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):250-6. PubMed ID: 24555863
[TBL] [Abstract][Full Text] [Related]
13. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.
Geevasinga N; Menon P; Nicholson GA; Ng K; Howells J; Kril JJ; Yiannikas C; Kiernan MC; Vucic S
JAMA Neurol; 2015 Nov; 72(11):1268-74. PubMed ID: 26348842
[TBL] [Abstract][Full Text] [Related]
14. Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers.
Vucic S; Winhammar JM; Rowe DB; Kiernan MC
Clin Neurophysiol; 2010 Oct; 121(10):1781-5. PubMed ID: 20362497
[TBL] [Abstract][Full Text] [Related]
15. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study.
Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S
Eur J Neurol; 2024 Jul; 31(7):e16281. PubMed ID: 38504632
[TBL] [Abstract][Full Text] [Related]
16. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
Vucic S; Kiernan MC
Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
[TBL] [Abstract][Full Text] [Related]
17. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
Vucic S; Cheah BC; Kiernan MC
Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
[TBL] [Abstract][Full Text] [Related]
18. Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS.
Geevasinga N; Menon P; Ng K; Van Den Bos M; Byth K; Kiernan MC; Vucic S
Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):580-588. PubMed ID: 27249331
[TBL] [Abstract][Full Text] [Related]
19. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis.
Zanette G; Tamburin S; Manganotti P; Refatti N; Forgione A; Rizzuto N
Clin Neurophysiol; 2002 Nov; 113(11):1688-97. PubMed ID: 12417221
[TBL] [Abstract][Full Text] [Related]
20. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
Vucic S; Kiernan MC
Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
